跳至主要内容
临床试验/TCTR20220423002
TCTR20220423002已完成4 期

Effectiveness of 0.3% Hyaluronic Acid Eye Drops in the Treatment of Benign Essential Blepharospasm and Hemifacial Spasm

Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.0 个研究点目标入组 47 人开始时间: 2022年4月23日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
47

研究概览

简要总结

After 3 months of treatment with 0.3% HA eye drops, patients with BEB and HSF experienced significant improvements in spasm score (p 0.030, p 0.013), TBUT (p 0.001, p 0.010), and mean corneal fluorescein staining grade (p 0.005, p 0.020). They also reported a significant improvement in the mean subjective dry eye symptom questionnaire score (p 0.010, p 0.007). All parameters in no intervention arm were not significantly changed.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • All patients with the diagnosis of BEB or HFS who were concurrently treated with BoNT-A injections, regardless of dry eye symptoms, and willing to enroll in the study.

排除标准

  • 1. neurological abnormalities other than craniocervical dystonia
  • 2. features suggestive of secondary dystonias
  • 3. history of other active ocular surface disorders or anterior segment diseases
  • 4. ocular trauma or eyelid/ocular surgery in the preceding 6 months
  • 5. contact lens wear
  • 6. concurrent application of any type(s) of artificial tears or other treatments for DED in the preceding 3 months.

研究者

发起方
Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

相似试验